Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study

Shun Lü(Shanghai Jiao Tong University), Jian Fang(Peking University), Xingya Li(First Affiliated Hospital of Zhengzhou University), Lejie Cao(University of Science and Technology of China), Jianying Zhou(Zhejiang University), Qisen Guo(Shandong First Medical University), Zongan Liang(Sichuan University), Ying Cheng(Jilin Province Tumor Hospital), Liyan Jiang(Shanghai Chest Hospital), Nong Yang(Central South University), Zhigang Han(Xinjiang Medical University), Jianhua Shi, Yuan Chen(Huazhong University of Science and Technology), Hua Xu(Second Affiliated Hospital of Nanchang University), Helong Zhang(Air Force Medical University), Gongyan Chen(Third Affiliated Hospital of Harbin Medical University), Rui Ma(Liaoning Cancer Hospital & Institute), Sanyuan Sun(Xuzhou Central Hospital), Yun Fan(Zhejiang Cancer Hospital), Jing Li, Xian Luo, Linfang Wang, Yongxin Ren, Weiguo Su
The Lancet Respiratory Medicine
June 21, 2021
Cited by 203

Abstract


Related Papers

No related papers found

Powered by citation graph analysis